Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature

Breast Cancer Research and Treatment

Volumn 120, Issue 1, 2010, Pages 119-126

  Kirova, Youlia M ^a   Savignoni, Alexia ^a   Sigal Zafrani, Brigitte ^a   De La Rochefordiere, Anne ^a   Salmon, Rémy J ^a   This, Pascale ^a   Asselain, Bernard ^a   Stoppa Lyonnet, Dominique ^a,b   Fourquet, Alain ^a  

^a INSTITUT CURIE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

BRCA1 2 mutations; Breast conserving treatment; Radiotherapy; Recurrence

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; ESTROGEN RECEPTOR;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC SCREENING; GERM LINE; HETEROZYGOTE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVARY CANCER; PREDICTOR VARIABLE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGE FACTORS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; GENES, BRCA1; GENES, BRCA2; HETEROZYGOTE; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; RETROSPECTIVE STUDIES;

EID: 74849086539     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0685-6     Document Type: Article

References (57)

1. ME Robson 2002 Clinical considerations in the management of individuals at risk for hereditary breast and ovarian cancer Cancer Control 9 457 465 12514563
2. C Adem C Reynolds CL Soderberg, et al. 2003 Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers Cancer 97 1 11 10.1002/cncr.11048 12491499 (Pubitemid 36033857)
3. PO Chappuis V Nethercot WD Foules, et al. 2000 Clinico-pathological characteristics of BRCA1 and BRCA2-related breast cancer Semin Surg Oncol 18 287 295 10.1002/(SICI)1098-2388(200006)18:4<287::AID-SSU3>3.0.CO;2-5 1:STN:280:DC%2BD3c3ms1CksQ%3D%3D 10805950
4. D Stoppa-Lyonnet Y Ansquer H Dreyfus, et al. 2000 Familial invasive breast cancers: worse outcome related to BRCA1 mutations J Clin Oncol 18 4053 4059 1:CAS:528:DC%2BD3MXktFegug%3D%3D 11118466
5. WD Foulkes PO Chappuis N Wong, et al. 2000 Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome Ann Oncol 11 307 313 10.1023/A:1008340723974 1:STN:280:DC%2BD3c3mvFKgtg%3D%3D 10811497 (Pubitemid 30214668)
6. LC Verhoog CTM Brekelmans C Seynaeve, et al. 1998 Survival and tumour characteristics of breast cancer patients with germline mutations of BRCA1 Lancet 351 316 321 10.1016/S0140-6736(97)07065-7 1:STN:280:DyaK1czhsVOiuw%3D%3D 9652611 (Pubitemid 28052696)
7. Breast Cancer Linkage Consortium 1997 Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases Lancet 349 1505 1510 10.1016/S0140-6736(96)10109-4 (Pubitemid 27216361)
8. SR Lakhani J Jacquemier JP Sloane, et al. 1998 Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations J Natl Cancer Inst 90 1138 1145 10.1093/jnci/90.15.1138 1:CAS:528:DyaK1cXlsVOrs78%3D 9701363
9. M Robson PO Chappuis J Satagopan, et al. 2004 A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment Breast Cancer Res 6 R8 R17 10.1186/bcr658 1:CAS:528:DC%2BD2cXnsl2hsw%3D%3D 14680495
10. A Venkitaraman 2002 Cancer susceptibility and the functions of BRCA1 and BRCA2 Cell 108 171 182 10.1016/S0092-8674(02)00615-3 1:CAS:528: DC%2BD38XhtV2hsLc%3D 11832208 (Pubitemid 34161138)
11. SN Powel LA Kachnic 2003 Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionising radiation Oncogene 22 5784 5791 10.1038/sj.onc.1206678 (Pubitemid 37176700)
12. A Baeyens H Thierens K Claes, et al. 2002 Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition Br J Cancer 87 1379 1385 10.1038/sj.bjc.6600628 1:CAS:528:DC%2BD38XovFKrsrY%3D 12454765 (Pubitemid 36044311)
13. P Freneaux D Stoppa-Lyonnet E Mouret, et al. 2000 Low expression of bcl-2 in Brca1-associated breast cancers Br J Cancer 83 1318 1322 10.1054/bjoc.2000.1438 1:CAS:528:DC%2BD3cXos12hu7g%3D 11044356
14. I Hedenfalk D Duggan Y Chen, et al. 2001 Gene-expression profiles in hereditary breast cancer N Engl J Med 344 539 548 10.1056/NEJM200102223440801 1:CAS:528:DC%2BD3MXhsFGks7o%3D 11207349 (Pubitemid 32167867)
15. D Cortez Y Wang J Qin, et al. 1999 Requirement of ATM-dependent phosphorylation of Brca1 in the DNA damage response to double-strand breaks Science 286 1162 1166 10.1126/science.286.5442.1162 1:CAS:528:DyaK1MXnt1Krsb4%3D 10550055 (Pubitemid 29522278)
16. R Scully J Chen RL Ochs, et al. 1997 Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage Cell 90 425 435 10.1016/S0092-8674(00)80503-6 1:CAS:528:DyaK2sXlsVKrsrc%3D 9267023 (Pubitemid 27347233)
17. X Xu Z Weaver SP Linke, et al. 1999 Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells Mol Cell 3 389 395 10.1016/S1097-2765(00)80466-9 1:CAS:528:DyaK1MXit1OmsLk%3D 10198641 (Pubitemid 29290679)
18. SG Brodie X Xu W Qiao, et al. 2000 Multiple genetic changes are associated with mammary tumorigenesis in BRCA1 conditional knockout mice Oncogene 20 7514 7523 10.1038/sj.onc.1204929
19. A Fourquet D Stoppa-Lyonnet B Sigal-Zafrani, et al. 2009 Familial invasive breast cancer: clinical response to induction chemotherapy or radiotherapy related to BRCA1 and BRCA2 mutations Am J Clin Oncol 32 127 131 10.1097/COC.0b013e31817f9e1c 1:CAS:528:DC%2BD1MXktVKitbo%3D 19307946
20. B Fisher S Anderson J Bryant, et al. 2002 Twenty-year follow-up of a randomised trial comparing total mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer N Engl J Med 347 1233 1241 10.1056/NEJMoa022152 12393820 (Pubitemid 35176242)
21. R Clark P McCullock M Levine, et al. 1992 Randomised clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer J Natl Cancer Inst 84 683 689 10.1093/jnci/84.9.683 1:STN:280:DyaK383jsFyqsg%3D%3D 1314910
22. JA Van Dongen AC Voogd IS Fentiman, et al. 2000 Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: EORTC 10801 trial J Natl Cancer Inst 92 1143 1150 10.1093/jnci/92.14.1143 10904087
23. U Veronesi N Cascinelli L Mariani, et al. 2002 Twenty-year follow-up of a randomised study comparing breast-conserving surgery with radical mastectomy for early breast cancer N Engl J Med 347 1227 1232 10.1056/NEJMoa020989 12393819 (Pubitemid 35176241)
24. JA Jacobson DN Danforth KH Cowan, et al. 1995 Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer N Engl J Med 332 907 911 10.1056/NEJM199504063321402 1:STN:280:DyaK2M7otlSqsw%3D%3D 7877647
25. M Blichert-Toft C Roce JA Anderson, et al. 1992 Danish randomised trial comparing breast conservation therapy with mastectomy: six years of life table analysis. Danish Breast Cancer Cooperative group J Natl Cancer Inst Monograms 11 19 25
26. R Arriagada MG Le JM Guinebretière, et al. 2003 Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients Ann Oncol 14 1617 1622 10.1093/annonc/mdg452 1:STN:280:DC%2BD3srgtlWqsg%3D%3D 14581268 (Pubitemid 37455809)
27. Early Breast Cancer Trialists' Collaborative Group 2005 Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Lancet 366 2087 2106
28. YM Kirova D Stoppa-Lyonnet A Savignoni, et al. 2005 Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy Eur J Cancer 41 2304 2311 10.1016/j.ejca.2005.02.037 16140006 (Pubitemid 41415607)
29. LJ Pierce M Strawderman SA Narod, et al. 2000 Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations J Clin Oncol 18 3360 3369 1:STN:280:DC%2BD3M%2FgvFWmtQ%3D%3D 11013276
30. L Pierce A Levin T Rebbeck, et al. 2006 Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer J Clin Oncol 24 2437 2443 10.1200/JCO.2005.02.7888 16636335 (Pubitemid 46630619)
31. CT Brekelmans MM Tilanus-Linthorst C Seynaeve, et al. 2007 Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases Eur J Cancer 43 5 867 876 10.1016/j.ejca.2006.12.009 1:CAS:528:DC%2BD2sXisleitLw%3D 17307353 (Pubitemid 46366688)
32. Delaloge S, Kloos I, Ariane D et al (2003) Young age is the major predictor of local relapse among conservatively treated BRCA1-, BRCA2-, or non BRCA-linked hereditary breast cancer. ASCO Proc 22(abstr 41):11
33. YM Kirova Y De Rycke L Gambotti, et al. 2008 Second malignancies after breast cancer: the impact of different treatment modalities Br J Cancer 98 870 874 10.1038/sj.bjc.6604241 1:CAS:528:DC%2BD1cXivVOgt7c%3D 18268495 (Pubitemid 351341602)
34. Y Kirova JR Vilcoq B Asselain, et al. 2005 Radiation-induced sarcomas (RIS) following radiotherapy for breast cancer: a large-scale single institution review Cancer 104 856 863 10.1002/cncr.21223 15981282 (Pubitemid 41113688)
35. D Thompson DF Easton 2002 The breast cancer linkage consortium: cancer incidence in BRCA1 mutation carriers J Natl Cancer Inst 94 1358 1365 1:CAS:528:DC%2BD38Xnt1Gnurs%3D 12237281
36. YM Kirova A Fourquet A Savignoni, et al. 2006 Risk of second non breast malignancies (SNBM) in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy Am J Immunol 2 61 63 10.3844/ajisp.2006.61.63
37. BG Haffty E Harrold AJ Khan, et al. 2002 Outcome of conservatively managed early-onset breast cancer by BRCA1/BRCA2 status Lancet 359 1471 1477 10.1016/S0140-6736(02)08434-9 11988246 (Pubitemid 34457765)
38. C Seynaeve LC Verhoog LM Van De Bosch, et al. 2004 Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy Eur J Cancer 40 1150 1158 10.1016/j.ejca.2004.01.017 1:STN:280:DC%2BD2c3ht1yrsQ%3D%3D 15110878 (Pubitemid 38526333)
39. Bremer M, Doerk T, Sohn C et al (2003): Local relapse after postoperative radiotherapy in patients with bilateral breast cancer by BRCA1/2 status. ASCO Proc 22(abstr 42):11
40. BC Turner E Harrold E Matloff, et al. 1999 BRCA1/BRCA2 germline mutations in locally recurrent breast cancer patients after lumpectomy and radiation therapy: implications for breast-conserving management in patients with BRCA1/BRCA2 mutations J Clin Oncol 17 3017 3024 1:STN:280:DyaK1MvjvVWltw%3D%3D 10506595
41. Garcia-Etienne CA, Barile M, Gentilini OD et al (2009) Breast-conserving surgery in BRCA1/2 mutation carriers: are we approaching an answer? Ann Surg Oncol (in press)
42. D Stoppa-Lyonnet P Laurent-Puig L Essioux, et al. 1997 BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group Am J Hum Genet 60 1021 1030 1:CAS:528:DyaK2sXjtlOru7c%3D 9150149
43. T Wagner D Stoppa-Lyonnet E Fleischmann, et al. 1999 Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations Genomics 62 369 376 10.1006/geno.1999.6026 1:CAS:528: DC%2BD3cXls1enuw%3D%3D 10644434 (Pubitemid 30075166)
44. EB Claus N Risch WD Thompson 1991 Genetic analysis of breast cancer in the cancer and steroid hormone study Am J Hum Genet 48 232 242 1:STN:280:DyaK3M7hvV2gsA%3D%3D 1990835
45. DF Easton DT Bishop D Ford, et al. 1993 Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium Am J Hum Genet 52 678 701 1:CAS:528:DyaK2cXhtVemurs%3D 8460634
46. RJ Salmon B Asselain M Le Gal, et al. 1997 Twelve years experience of breast cancer at the Institut Curie: improvement of survival and value of screening mammographics Breast 6 202 205 10.1016/S0960-9776(97)90574-9 (Pubitemid 27470151)
47. Y Kirova V Servois F Campana, et al. 2006 CT- scan based localization of the internal mammary chain and supra clavicular nodes for breast cancer radiation therapy planning Radiother Oncol 79 310 315 10.1016/j.radonc.2006.05. 014 16766067 (Pubitemid 44109910)
48. F Campana YM Kirova JC Rosenwald, et al. 2005 Breast radiotherapy in the lateral decubitus position-a technique to prevent lung and heart irradiation Int J Radiat Oncol Biol Phys 61 1348 1354 15817336
49. YM Kirova N Fournier-Bidoz V Servois, et al. 2008 How to boost the breast tumor bed? A multidisciplinary approach in 8 steps Int J Radiat Oncol Biol Phys 72 494 500 18374516
50. EL Kaplan P Meier 1958 Non-parametric estimation from incomplete observations J Am Stat Assoc 53 457 481 10.2307/2281868
51. N Mantel 1966 Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chemother Rep 50 163 170 1:STN:280:DyaF287ht1Wgug%3D%3D 5910392
52. DR Cox 1972 Regression models and life tables J R Stat Soc 34 187 220
53. SA Narod JS Brunet P Ghadirian, et al. 2000 Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study Lancet 356 1876 1881 10.1016/S0140-6736(00)03258-X 1:CAS:528: DC%2BD3cXovFWjsL8%3D 11130383
54. L Pierce 2002 Radiotherapy for breast cancer in BRCA1/BRCA2 carriers: clinical issues and management dilemmas Semin Radiat Oncol 12 352 361 10.1053/srao.2002.35254 12382193 (Pubitemid 35204825)
55. EJ Meijers-Heijboer LC Verhoog CTM Brekelmans, et al. 2000 Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation Lancet 355 2015 2020 10.1016/S0140-6736(00)02347-3 1:CAS:528: DC%2BD3cXksl2lt7s%3D 10885351
56. A Reicht 2009 Contralateral prophylactic mastectomy: caveat emptor J Clin Oncol 27 1347 1349 10.1200/JCO.2008.21.0518
57. Y Drew H Calvert 2008 The potential of PARP inhibitors in genetic breast and ovarian cancers Ann N Y Acad Sci 1138 136 145 10.1196/annals.1414.020 1:CAS:528:DC%2BD1cXhtlemsLnF 18837894